We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ARTV market cap is 248.24M. The company's latest EPS is USD -1.1824 and P/E is -8.64.
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|
USD ($) | |||
Total Revenue | 251k | 0 | 0 |
Operating Income | -14.49M | -16.19M | -18.33M |
Net Income | -13.96M | -17.84M | -17.47M |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Revenue | 33.49M |
Operating Income | -30.67M |
Net Income | -28.72M |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|
USD ($) | |||
Total Assets | 90.16M | 75.91M | 225.6M |
Total Liabilities | 48.42M | 50.6M | 24.6M |
Total Equity | -174.67M | -191.1M | 201M |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Assets | 105.11M |
Total Liabilities | 50.72M |
Total Equity | -162.02M |
Market Cap | 248.24M |
Price to Earnings Ratio | -8.64 |
Price to Sales Ratio | 7.41 |
Price to Cash Ratio | 4.64 |
Price to Book Ratio | 4.56 |
Dividend Yield | - |
Shares Outstanding | 24.29M |
Average Volume (1 week) | 49.17k |
Average Volume (1 Month) | 67.62k |
52 Week Change | -36.13% |
52 Week High | 17.31 |
52 Week Low | 9.68 |
Spread (Intraday) | 0.31 (2.98%) |
Company Name | Artiva Biotherapeutics Inc |
Address |
838 walker rd, suite 21-2 dover, delaware 19904 |
Website | https://www.artivabio.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions